Cargando…

Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study

INTRODUCTION: Serum Mucorales PCR can precede the final diagnosis of invasive mucormycosis by several days or weeks and could therefore be useful as a non-invasive screening tool. METHODS: We assessed the performance of a commercial Mucorales PCR assay (MucorGenius®, PathoNostics, Maastricht, The Ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Aerts, Robina, Bevers, Sien, Beuselinck, Kurt, Schauwvlieghe, Alexander, Lagrou, Katrien, Maertens, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774025/
https://www.ncbi.nlm.nih.gov/pubmed/36569194
http://dx.doi.org/10.3389/fcimb.2022.1080921
_version_ 1784855310584774656
author Aerts, Robina
Bevers, Sien
Beuselinck, Kurt
Schauwvlieghe, Alexander
Lagrou, Katrien
Maertens, Johan
author_facet Aerts, Robina
Bevers, Sien
Beuselinck, Kurt
Schauwvlieghe, Alexander
Lagrou, Katrien
Maertens, Johan
author_sort Aerts, Robina
collection PubMed
description INTRODUCTION: Serum Mucorales PCR can precede the final diagnosis of invasive mucormycosis by several days or weeks and could therefore be useful as a non-invasive screening tool. METHODS: We assessed the performance of a commercial Mucorales PCR assay (MucorGenius®, PathoNostics, Maastricht, The Netherlands) on prospectively collected banked sera from hematology patients at risk for invasive mould infections. We evaluated if there is an underestimated incidence of missed Mucorales co-infections in patients with invasive aspergillosis (IA). We tested Mucorales PCR on the sera of all patients with a diagnosis of at least possible IA (EORTC-MSGERC consensus criteria) before the start of any antifungal therapy, and in a control group of similar high-risk hematology patients without IA (in a 1:4 ratio). When a positive Mucorales PCR was observed, at least 5 serum samples taken before and after the positive one were selected. RESULTS: Mucorales PCR was performed in 46 diagnostic serum samples of cases and in 184 controls. Serum Mucorales PCR was positive in 4 cases of IA (8.7%; 12.9% of probable cases) and in 1 control case (0.5%) (p=0.0061, OR=17.43 (1.90-159.96). Post-mortem cultures of the positive control became positive for Rhizopus arrhizus. Mortality of IA cases with and without a positive Mucorales PCR was not significantly different. Only in the PCR positive control case, serial serum samples before and after the diagnostic sample were also positive. DISCUSSION: It is not entirely clear what a positive Mucorales PCR in these cases implies since the 4 Mucorales PCR positive cases were treated with antifungals with activity against Mucorales. In addition, PCR was positive only once. This study does not provide enough evidence to implement Mucorales PCR screening. However, our findings emphasize once more the importance of considering the possibility of dual mould infections, even in patients with a positive galactomannan detection.
format Online
Article
Text
id pubmed-9774025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97740252022-12-23 Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study Aerts, Robina Bevers, Sien Beuselinck, Kurt Schauwvlieghe, Alexander Lagrou, Katrien Maertens, Johan Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: Serum Mucorales PCR can precede the final diagnosis of invasive mucormycosis by several days or weeks and could therefore be useful as a non-invasive screening tool. METHODS: We assessed the performance of a commercial Mucorales PCR assay (MucorGenius®, PathoNostics, Maastricht, The Netherlands) on prospectively collected banked sera from hematology patients at risk for invasive mould infections. We evaluated if there is an underestimated incidence of missed Mucorales co-infections in patients with invasive aspergillosis (IA). We tested Mucorales PCR on the sera of all patients with a diagnosis of at least possible IA (EORTC-MSGERC consensus criteria) before the start of any antifungal therapy, and in a control group of similar high-risk hematology patients without IA (in a 1:4 ratio). When a positive Mucorales PCR was observed, at least 5 serum samples taken before and after the positive one were selected. RESULTS: Mucorales PCR was performed in 46 diagnostic serum samples of cases and in 184 controls. Serum Mucorales PCR was positive in 4 cases of IA (8.7%; 12.9% of probable cases) and in 1 control case (0.5%) (p=0.0061, OR=17.43 (1.90-159.96). Post-mortem cultures of the positive control became positive for Rhizopus arrhizus. Mortality of IA cases with and without a positive Mucorales PCR was not significantly different. Only in the PCR positive control case, serial serum samples before and after the diagnostic sample were also positive. DISCUSSION: It is not entirely clear what a positive Mucorales PCR in these cases implies since the 4 Mucorales PCR positive cases were treated with antifungals with activity against Mucorales. In addition, PCR was positive only once. This study does not provide enough evidence to implement Mucorales PCR screening. However, our findings emphasize once more the importance of considering the possibility of dual mould infections, even in patients with a positive galactomannan detection. Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9774025/ /pubmed/36569194 http://dx.doi.org/10.3389/fcimb.2022.1080921 Text en Copyright © 2022 Aerts, Bevers, Beuselinck, Schauwvlieghe, Lagrou and Maertens https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Aerts, Robina
Bevers, Sien
Beuselinck, Kurt
Schauwvlieghe, Alexander
Lagrou, Katrien
Maertens, Johan
Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study
title Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study
title_full Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study
title_fullStr Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study
title_full_unstemmed Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study
title_short Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study
title_sort blood mucorales pcr to track down aspergillus and mucorales co-infections in at-risk hematology patients: a case-control study
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774025/
https://www.ncbi.nlm.nih.gov/pubmed/36569194
http://dx.doi.org/10.3389/fcimb.2022.1080921
work_keys_str_mv AT aertsrobina bloodmucoralespcrtotrackdownaspergillusandmucoralescoinfectionsinatriskhematologypatientsacasecontrolstudy
AT beverssien bloodmucoralespcrtotrackdownaspergillusandmucoralescoinfectionsinatriskhematologypatientsacasecontrolstudy
AT beuselinckkurt bloodmucoralespcrtotrackdownaspergillusandmucoralescoinfectionsinatriskhematologypatientsacasecontrolstudy
AT schauwvlieghealexander bloodmucoralespcrtotrackdownaspergillusandmucoralescoinfectionsinatriskhematologypatientsacasecontrolstudy
AT lagroukatrien bloodmucoralespcrtotrackdownaspergillusandmucoralescoinfectionsinatriskhematologypatientsacasecontrolstudy
AT maertensjohan bloodmucoralespcrtotrackdownaspergillusandmucoralescoinfectionsinatriskhematologypatientsacasecontrolstudy